Photodynamic therapy in dermatology

Archives of Dermatology

Volumn 134, Issue 2, 1998, Pages 207-214

  Fritsch, Clemens ^a   Goerz, Günter ^a   Ruzicka, Thomas ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; DIAGNOSTIC PROCEDURE; DRUG METABOLISM; HEADACHE; HUMAN; LIGHT; LIVER TOXICITY; NAUSEA; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PSORIASIS; REVIEW; SHOCK; SKIN TUMOR; TREATMENT INDICATION; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, CUTANEOUS; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL DEATH; FLUORESCENCE; FREE RADICALS; HUMANS; KERATOSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; REACTIVE OXYGEN SPECIES; SKIN DISEASES; SKIN NEOPLASMS; SUNLIGHT;

EID: 0031885533     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.2.207     Document Type: Review

References (46)

1. Pass HI. Photodynamic therapy in oncology: mechanism and clinical use. J Natl Cancer Inst. 1993;85:443-456.
2. Fisher AMR, Murphree AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med. 1995;17:2-31.
3. Fritsch C, Becker-Wegerich PM, Schulte KW, et al. Treatment of a large superficial basal cell carcinoma of the breast: combination of photodynamic therapy and surgery controlled by photodynamic diagnosis. Hautarzt. 1996;47:438-442.
4. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid: an alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol. 1993;28:17-21.
5. Lui H, Hruza L, McLean D, et al. Photodynamic therapy of malignant skin tumors with BPD verteporfin (benzoporphyrin derivative). Lasers Surg Med. 1995; 7(suppl):44. Abstract.
6. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer. 1994;69:605-608.
7. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;6:143-148.
8. Peng Q, Moan J, Warloe T, et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B. 1996;34:95-96.
9. Fritsch C, Abels C, Goetz AE, et al. Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid. Biol Chem. 1997; 378:51-57.
10. Fritsch C, Batz J, Bolsen K, et al. Ex vivo-application of δ-aminolevulinic acid induces high and specific porphyrin levels in human skin tumors: possible basis for selective photodynamic therapy. Photochem Photobiol. 1997;66:114-118.
11. Hruza L, Lui H, Hruza G, et al. Response of psoriasis to photodynamic therapy using benzoporphyrin derivative monoacid ring A. Lasers Surg Med. 1995;7 (suppl):43-44. Abstract.
12. Richter AM, Chowdary R, Ratkay L, et al. Non-oncologic potentials for photodynamic therapy. SPIE Proc. 1993;2078:293-304.
13. Dellian M, Richert C, Gamarra F, Goetz AE. Photodynamic eradication of amelanotic melanoma of the hamster with fast acting photosensitizers. Int J Cancer. 1996;65:246-248.
14. Fritsch C, Verwohlt B, Bolsen K, Ruzicka T, Goerz G. Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism. Arch Dermatol Res. 1996;288:517-521.
15. Peng Q, Warloe T, Moan J, et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol. 1995; 62:906-913.
16. Szeimies RM, Hein R, Bäumler W, Heine A, Landthaler M. A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Dermatol Venereol. 1994;74:117-119.
17. Szeimies RM, Abels C, Fritsch C, et al. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. J Invest Dermatol. 1995;105:672-677.
18. Rebeiz N, Arkins S, Rebeiz CA, et al. Induction of tumor necrosis by delta-aminolevulinic acid and 1,10-phenanthroline photodynamic therapy. Cancer Res. 1996;56:339-344.
19. Fijan S, Hönigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol. 1995; 133:282-288.
20. Lui H, Anderson RR. Photodynamic therapy in dermatology: recent developments. Dermatol Clin. 1993;11:1-13.
21. Dougherty TJ. Photoradiation therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol. 1981;77:122-124.
22. Wilson BD, Mang T, Stoll H, Jones C, Cooper M, Dougherty TJ. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol. 1992;128: 1597-1601.
23. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical δ-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B. 1995;29:53-57.
24. Svanberg K, Anderson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation. Br J Dermatol. 1994;130:743-751.
25. Lui H, Salasche S, Kollias N, Wimberly J, Flotte T, McLean D, Anderson RR. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study. Arch Dermatol. 1995;131:737-738.
26. Warloe T, Peng Q, Moan J, Qvist HL, Giercksky KE. Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid. In: Spinelli P, Dal Fante M, Marchesini R, eds. Photodynamic Therapy and Biochemical Lasers. Amsterdam, the Netherlands: Elsevier Science Publishers; 1992:449-453.
27. Pennington DG, Waner M, Knox A. Photodynamic therapy for multiple skin cancers. Plast Reconstr Surg. 1988;82:1067-1071.
28. Jones CM, Mang T, Cooper M, Wilson BD, Stoll HL. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol. 1992;27:979-982.
29. Robinson PJ, Carruth JAS, Fairris GM. Photodynamic therapy: a better treatment for widespread Bowen's disease. Br J Dermatol. 1988;119:59-61.
30. Buchanan RB, Carruth JAS, McKenzie AL, Williams SR. Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur J Surg Oncol. 1989;15:400-406.
31. Nauta JM, Van Leengoed HLLM, Star WM, et al. Photodynamic therapy of oral cancer: a review of basic mechanisms and clinical applications. Eur J Oral Sci. 1996;104:69-81.
32. Stables GI, Stringer MR, Ash DV. The treatment of erythroplasia of Queyrat by topical aminolevulinic acid photodynamic therapy. Br J Dermatol. 1995;133 (suppl 45):30. Abstract.
33. Stender IM, Wulf HC. Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis. Br J Dermatol. 1996;135:454-456.
34. Wolf P, Kerl H. Photodynamic therapy on a patient with xeroderma pigmentosum. Lancet. 1991;337:1613-1614.
35. Martin A, Tope WD, Grevelink JM, et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res. 1995; 287:665-674.
36. Lowdell CP, Ash DV, Driver I, Brown SB. Interstitial photodynamic therapy: clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumors. Br J Cancer. 1993;67:1398-1403.
37. Khan SA, Dougherty TJ, Mang TS. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur J Cancer. 1993; 29A:1686-1690.
38. Wolf P, Fink-Puches R, Cerroni L, Kerl H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol. 1994;31:678-680.
39. Ammann R, Hunziker T. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol. 1995;33:541.
40. Schweitzer VG, Visscher D. Photodynamic therapy for treatment of AIDS-related oral Kaposi's sarcoma. Otolaryngol Head Neck Surg. 1990;102:639-649.
41. Berns MW, Rettenmaier M, McCullough J. Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative. Lasers Surg Med. 1984;4:73-77.
42. Pres H, Meffert H, Sonnichson N. Photodynamic therapy of psoriasis palmaris et plantaris using topically applied hematoporphyrin derivative and visible light. Dermatol Monatsschr. 1989;175:745-750.
43. Boehncke WH, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 1994;343:801.
44. Stringer MR, Collins P, Robinson DJ, Stables GI, Sheehan-Dare RA. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for photo_dynamic therapy. J Invest Dermatol. 1996;107:76-81.
45. Fritsch C, Kalka K, Lehmann P, et al. Fluorescence detection of δ-aminolevulinic acid-induced porphyrins (photodynamic diagnosis) in dermatology. Z Hautkr H G. 1997;72:570-576.
46. Fritsch C, Becker-Wegerich PM, Menke M, Ruzicka T, Goerz G, Olbrisch RR. Successful surgery of multiple recurrent basal cell carcinomas guided by photodynamic diagnosis. Aesthetic Plast Surg. 1997;21:437-439.